Both in Diagnostics
Idexx Laboratories vs Myriad Genetics
Over the past year IDXX returned −7.0% and MYGN returned −26.2%; their daily moves had a correlation of 0.06.
IDXX −7.0% MYGN −26.2%Growth of $1, one year, split-adjusted
| Metric | IDXX | MYGN |
|---|---|---|
| Price | $672.04 | $6.04 |
| Market cap | $52.94B | $577.7M |
| Today | +0.06% | +3.25% |
| 1 month | +27.5% | +31.9% |
| 6 months | +19.4% | +20.1% |
| Year to date | −0.7% | −1.8% |
| 1 year | +6.8% | −24.9% |
| Revenue growth (YoY) | +9.9% | −10.5% |
| Gross margin | 62.9% | 66.6% |
| Net margin | 26.1% | −22.7% |
| P/E (TTM) | 44.8× | — |
| Price / sales | 11.4× | 0.7× |
| Net cash | -$651.3M | -$5.5M |
| Dividend yield | — | — |
| Volatility (60d) | 48.0% | 85.1% |
| Short % of float | 2.5% | 10.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).